Pancreatic Cancer
Conditions
Interventions
the integrated Traditional Cthinese and Western Medicine treatment group:No
the control group (chemotherapy alone):No
Sponsors
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: ? Patients diagnosed with pancreatic cancer based on imaging and/or pathological examination.; ? Patients who received chemotherapy as the primary treatment regimen, with at least two sessions of regular chemotherapy.; ? Complete and accurate clinical data available.
Exclusion criteria
Exclusion criteria: ? Patients who do not meet the Western medical diagnosis, traditional Chinese medicine pattern identification and symptom presentation criteria; ? Patients with severe primary diseases of the liver, kidney, hematopoietic system, immune system, etc.; ? Pregnant or lactating women; ? Incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CA19-9;CEA;Leukocyte count;Hemoglobin;Neutrophil count;Lymphocyte count;Platelet count;D-dimer;Fibrinogen;C-reactive protein,CRP;Total protein;Globulin;Albumin;Total bilirubin;Conjugated bilirubin;Indirect bilirubin;ALT;AST;Creatinine;Urea;Fasting blood glucose;BMI;Overall survival;Adverse reactions; | — |
Countries
China
Contacts
Public ContactWang Yu
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Outcome results
None listed